Results from Clinical Trial of Veliparib for People with Unmethylated Glioblastoma Bookmark

This scientific report from Neuro-Oncology outlines findings from a large, randomized clinical trial showing that the drug veliparib (a kind of drug known as a PARP inhibitor) added to radiotherapy and temozolomide did not improve progression-free survival in unmethylated glioblastoma.

.

New Chronic Lymphocytic Leukemia Treatments 2021 Bookmark

TheSocialMedwork outlines several new drugs for treating chronic lymphocytic leukemia, including Brukinsa (zanubrutinib).

.

Latest Advances in the Management of Classical Hodgkin Lymphoma: The Era of Novel Therapies Bookmark

This academic review paper from Blood Cancer Journal outlines many recent advances in the treatment of Hodgkin lymphoma, including for the 15-30% of patients who do not respond or relapse after conventional treatment.

.

New Approvals for Liver Cancer Mark ‘Golden Age’ of Treatment Bookmark

Reported in Healio: After decades of little or no progress, many new clinical trials testing targeted and immunotherapy drugs—especially in combinations—are showing that they have real value in treating primary liver cancer (hepatocellular carcinoma).

.

Oncolytic Virus Teserpaturev Approved in Japan for Malignant Glioma Bookmark

Oncolytic viruses may offer serious hope as a very new type of treatment for malignant glioma. As reported by OncLive, the oncolytic virus teserpaturev was recently approved in Japan after a phase 2 clinical trial.

.

.

2021 ASCO Annual Meeting Bookmark

Researchers at the 2021 annual meeting of the American Society of Clinical Oncology (ASCO) reported substantial advances in treatment for advanced esophageal, castration-resistant prostate, and metastatic nasopharyngeal cancers.

.

ARIEL4 Trial Confirms PFS Benefit of Rucaparib in BRCA+ Relapsed Ovarian Cancer Bookmark

As reported by Cancer Network, new results from a phase 3 clinical trial testing the drug rucaparib (Rubraca), which has already been approved by the U.S. Food and Drug Administration, show that it prolongs progression-free survival in some patients with advanced ovarian cancer.

.

FDA Approves First Targeted Therapy for Lung Cancer Mutation Previously Considered Resistant to Drug Therapy Bookmark

On May 28, 2021, the U.S. Food and Drug Administration granted Accelerated Approval for Lumakras (sotorasib), the first targeted therapy for cancer with a mutation in the KRAS gene.

.

Advances in Colorectal Cancer Research Bookmark

This outline from the National Cancer Institute covers recent research on colorectal cancer.

.

Cancer Support for LGBTQIA Patients Is Missing Bookmark

This piece from ASCO Connection outlines the need for and a path to improvement in cancer care for LGBTQIA patients.

.